TABLE 4.
Longitudinal testing of patient 219 sample
| Test date (day/mo/yr) | TPHA titer | IgG FTA-ABS score | Resulta for indicated test
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19S-IgM-FTA-ABS | IgM-EIA | VDRL | IgG (MarDx) immunoblotting
|
IgM (MarDx) immunoblotting
|
|||||||||
| 47 | 17 | 15 | Overall | 47 | 17 | 15 | Overall | ||||||
| 14/09/98 | 160 | 1+ | Pos | Pos | Neg | Ind | Neg | Neg | Neg | Ind | Neg | Neg | Neg |
| 9/10/98 | 80 | 1+ | Pos | Neg | Neg | Pos | Neg | Neg | Ind | Ind | Neg | Neg | Neg |
| 23/11/98 | <80 | 1+ | Ind | Neg | Neg | ||||||||
| 6/01/99 | <80 | 1+ | Ind | Neg | Neg | ||||||||
| 17/02/99 | <80 | 1+ | Ind | Neg | Neg | ||||||||
| 26/05/99 | <80 | 1+ | Ind | Neg | Neg | ||||||||
a
Pos, positive; Neg, negative; Ind, indeterminate; 47, 17, 15, T. pallidum native antigens of 47, 17, and 15.5 kDa, respectively.